DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 1d ago
0OG logo

Organigram Global Inc.DB:0OG Stock Report

Market Cap €134.1m
Updated 1d ago
Share Price
n/a
1Y-30.2%
7D-5.4%
1D-3.4%
Portfolio Value
​
View

Organigram Global Inc.

DB:0OG Stock Report

Market Cap: €134.1m

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Organigram Global (0OG) Stock Overview

Engages in the production and sale of cannabis and cannabis-derived products in Canada. More details

0OG fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance4/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 94.4% below our estimate of its fair value

Revenue is forecast to grow 14.51% per year

Earnings grew by 1014.5% over the past year

Trading at good value compared to peers and industry

Risk Analysis

High level of non-cash earnings

Earnings are forecast to decline by an average of 87.7% per year for the next 3 years

Volatile share price over the past 3 months compared to the German market


0OG Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW436,082 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
436,082 investors already sharing narratives
€
Current Price
€0.9433.2% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-224m609m2016201920222025202620282031Revenue CA$608.8mEarnings CA$170.6m
Advanced
View all narratives

Organigram Global Inc. Competitors

Dermapharm Holding

Symbol: XTRA:DMP
Market cap: €1.9b

Alexandria For Pharmaceuticals & Chemical Industries

Symbol: CASE:AXPH
Market cap: ج.م8.3b

Fermenta Biotech

Symbol: BSE:506414
Market cap: ₹14.2b

MINAPHARM Pharmaceuticals

Symbol: CASE:MIPH
Market cap: ج.م9.6b

Price History & Performance

Summary of share price highs, lows and changes for Organigram Global
Historical stock prices
Current Share PriceCA$0.94
52 Week HighCA$1.82
52 Week LowCA$0.74
Beta1.91
1 Month Change12.65%
3 Month Change4.94%
1 Year Change-30.22%
3 Year Change-41.93%
5 Year Change-89.14%
Change since IPO-84.79%

Recent News & Updates

Recent updates

Shareholder Returns

0OGDE PharmaceuticalsDE Market
7D-5.4%-2.7%-0.5%
1Y-30.2%40.5%4.6%

Return vs Industry: 0OG underperformed the German Pharmaceuticals industry which returned 40.8% over the past year.

Return vs Market: 0OG underperformed the German Market which returned 5.5% over the past year.

Price Volatility

Is 0OG's price volatile compared to industry and market?
0OG volatility
0OG Average Weekly Movement9.6%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.0%
10% most volatile stocks in DE Market12.4%
10% least volatile stocks in DE Market2.5%

Stable Share Price: 0OG's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 0OG's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a1,120James Yamanakawww.organigram.ca

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers.

Organigram Global Inc. Fundamentals Summary

How do Organigram Global's earnings and revenue compare to its market cap?
0OG fundamental statistics
Market cap€134.11m
Earnings (TTM)€53.93m
Revenue (TTM)€192.50m
2.5x
P/E Ratio
0.7x
P/S Ratio

Is 0OG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0OG income statement (TTM)
RevenueCA$309.18m
Cost of RevenueCA$196.19m
Gross ProfitCA$112.98m
Other ExpensesCA$26.36m
EarningsCA$86.62m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.62
Gross Margin36.54%
Net Profit Margin28.02%
Debt/Equity Ratio3.8%

How did 0OG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 11:08
End of Day Share Price 2026/09/09 00:00
Earnings2026/06/30
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Organigram Global Inc. is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Frederico Yokota Choucair GomesATB Cormark
Jesse PytlakATB Cormark Historical (Cormark Securities)

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide